164 related articles for article (PubMed ID: 38735008)
1. ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway.
Liu Y; Zeng D; Gao Y
Discov Oncol; 2024 May; 15(1):158. PubMed ID: 38735008
[TBL] [Abstract][Full Text] [Related]
2. ZNF692 promote proliferation through transcriptional repression of essential genes in clear cell renal carcinoma.
Wang H; Zhao J; He H; Xie X; Dai J; Xu D; Huang X
Biochem Biophys Res Commun; 2023 Sep; 671():255-262. PubMed ID: 37307709
[TBL] [Abstract][Full Text] [Related]
3. ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma.
Zhang Q; Zheng X; Sun Q; Shi R; Wang J; Zhu B; Xu L; Zhang G; Ren B
Biochem Biophys Res Commun; 2017 Sep; 490(4):1189-1196. PubMed ID: 28669730
[TBL] [Abstract][Full Text] [Related]
4. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract][Full Text] [Related]
5.
Klümper N; Ralser DJ; Zarbl R; Schlack K; Schrader AJ; Rehlinghaus M; Hoffmann MJ; Niegisch G; Uhlig A; Trojan L; Steinestel J; Steinestel K; Wirtz RM; Sikic D; Eckstein M; Kristiansen G; Toma M; Hölzel M; Ritter M; Strieth S; Ellinger J; Dietrich D
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446578
[TBL] [Abstract][Full Text] [Related]
6. ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway.
Xing Y; Ren S; Ai L; Sun W; Zhao Z; Jiang F; Zhu Y; Piao D
Int J Oncol; 2019 May; 54(5):1691-1703. PubMed ID: 30816443
[TBL] [Abstract][Full Text] [Related]
7. A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
Zhu B; Pan Y; Zheng X; Zhang Q; Wu Y; Luo J; Li Q; Lu E; Xu L; Jin G; Ren B
Gynecol Oncol; 2019 Feb; 152(2):396-407. PubMed ID: 30466806
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma].
Cai TY; Zhu ZP; Xu CR; Ji X; Lv TD; Guo ZK; Lin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):628-635. PubMed ID: 35950384
[TBL] [Abstract][Full Text] [Related]
9. Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining.
Xu Z; Wang Y; Xu J; Ang X; Ge N; Xu M; Pei C
Heliyon; 2023 Feb; 9(2):e13543. PubMed ID: 36846683
[TBL] [Abstract][Full Text] [Related]
10. CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells.
Wang K; Ding Y; Liu Y; Ma M; Wang J; Kou Z; Liu S; Jiang B; Hou S
J Cell Mol Med; 2024 Apr; 28(7):e18165. PubMed ID: 38494845
[TBL] [Abstract][Full Text] [Related]
11. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
[TBL] [Abstract][Full Text] [Related]
12. The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
Heyliger SO; Soliman KFA; Saulsbury MD; Reams RR
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439859
[TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival.
Qiang Y; Wang X; Ding J; Wang Z; Li B; Ji H; Zhang X; Yang Y; Liu K; Zhang L; Ma S; Zhao D; Lu G
Clin Genitourin Cancer; 2023 Apr; 21(2):e78-e91. PubMed ID: 36127253
[TBL] [Abstract][Full Text] [Related]
14. ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment.
Chen WJ; Yang W; Gong M; He Y; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Dong KQ; Song X; Pan XW; Cui XG
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562383
[TBL] [Abstract][Full Text] [Related]
15. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
Zhang J; Wang Y; Ma J; Aimudula A
Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
17. PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study.
Chang Q; Sun J; Zhao S; Li L; Zhang N; Yan L; Fan Y; Liu J
Aging (Albany NY); 2023 Nov; 15(23):13753-13775. PubMed ID: 38048211
[TBL] [Abstract][Full Text] [Related]
18. ZNF692 promotes cell proliferation, invasion and migration of human prostate cancer cells by targeting the EMT signaling pathway.
Chen H; Li Y; Wu G; Zeng Q; Huang H; Zhang G
Eur J Med Res; 2024 Jan; 29(1):88. PubMed ID: 38291502
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
[TBL] [Abstract][Full Text] [Related]
20. A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients.
Shen C; Chen Z; Jiang J; Zhang Y; Xu W; Peng R; Zuo W; Jiang Q; Fan Y; Fang X; Zheng B
Front Genet; 2022; 13():1034567. PubMed ID: 36246657
[No Abstract] [Full Text] [Related]
[Next] [New Search]